Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1421811
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1421811
Oncology Companion Diagnostic Market Share, Size, Trends, Industry Analysis Report, By Offering (Product, Services); By Technology; By Disease Type; By End User; By Region; Segment Forecast, 2023- 2032
PUBLISHED:
PAGES: 114 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global oncology companion diagnostic market size is expected to reach USD 10.57 billion by 2032, according to a new study by Polaris Market Research. The report "Oncology Companion Diagnostic Market Share, Size, Trends, Industry Analysis Report, By Offering (Product, Services); By Technology; By Disease Type; By End User; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The shift towards patient-centered healthcare has created a favorable environment for companion diagnostics. These tools enable healthcare providers to design tailored treatment plans, minimizing side effects and optimizing patient outcomes. This patient-centric approach is increasingly valued in the healthcare landscape. The rising awareness of companion diagnostics among patients provides an opportunity for increased adoption. Engaging patients in their care and empowering them with information about the benefits of these diagnostics drives market growth.
Companion diagnostics offer a route to more cost-effective healthcare. By reducing the use of ineffective therapies and minimizing the occurrence of hospitalizations and complications, these tools contribute to healthcare cost containment. The market benefits from ongoing research efforts aimed at discovering new biomarkers and genetic markers associated with various cancer types. These discoveries expand the applications of companion diagnostics, opening up new opportunities for market growth.
Emerging economies offer a significant growth opportunity. As these regions improve healthcare infrastructure and increase awareness, the adoption of companion diagnostics is poised for substantial growth. The expansion of telemedicine and remote diagnostics in healthcare presents opportunities to increase access to companion diagnostic testing. This trend, particularly relevant in underserved or remote areas, broadens the market's reach.
The ongoing innovations in diagnostic technologies, including liquid biopsies and next-generation sequencing, present opportunities for more accurate and comprehensive companion diagnostics. These innovations can lead to greater diagnostic precision and expanded testing capabilities.
Oncology Companion Diagnostic Market Report Highlights
Product segment held a significant share in 2022, owing to growing cancer prevalence, global aging population, and advancements in precision medicine
Immunohistochemistry emerged as the largest segment on account of its wide use in biomarker detection, subtype classification, and treatment guidance
The breast cancer segment is expected to experience significant growth during the forecast period, which is mainly driven by its growing adoption of targeted therapies and regulatory support
Hospitals segment held the maximum market revenue share in 2022, mainly for early detection and diagnosis, treatment monitoring, and patient-centric care
North America region dominated the market with majority share in 2022, owing to the rise of personalized medicine, regulatory framework, and partnerships and collaborations
The global key market players include: Abbott Laboratories, Agilent Technologies, Illumina, Invivoscribe, Roche Diagnostics, Sysmex Corporation, and Thermo Fisher Scientific, among others
Polaris Market Research has segmented the Oncology Companion Diagnostic market report based on offering, technology, disease type, end user, and region:
Oncology Companion Diagnostic, Offering Outlook (Revenue - USD Billion, 2019 - 2032)
- Product
- Services
Oncology Companion Diagnostic, Technology Outlook (Revenue - USD Billion, 2019 - 2032)
- Immunohistochemistry
- Next-Generation Sequencing
- Polymerase Chain Reaction
- Others
Oncology Companion Diagnostic, Disease Type Outlook (Revenue - USD Billion, 2019 - 2032)
- Melanoma
- Breast Cancer
- Colorectal Cancer
- Leukaemia
- Prostate Cancer
- Others
Oncology Companion Diagnostic, End User Outlook (Revenue - USD Billion, 2019 - 2032)
- Hospitals
- Diagnostic Labs
- Others
Oncology Companion Diagnostic, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Product Code: PM4133
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Oncology Companion Diagnostic Market Insights
- 4.1. Oncology Companion Diagnostic - Industry Snapshot
- 4.2. Oncology Companion Diagnostic Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising cancer cases, growing availability of targeted cancer therapies, and precision medicine advancements
- 4.2.1.2. Growing emphasis on personalized medicine
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Regulatory challenges and approval processes
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Oncology Companion Diagnostic Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Oncology Companion Diagnostic Market, by Technology
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 5.3. Immunohistochemistry
- 5.3.1. Global Oncology Companion Diagnostic Market, by Immunohistochemistry, by Region, 2019-2032 (USD Billion)
- 5.4. Next-Generation Sequencing
- 5.4.1. Global Oncology Companion Diagnostic Market, by Next-Generation Sequencing, by Region, 2019-2032 (USD Billion)
- 5.5. Polymerase Chain Reaction
- 5.5.1. Global Oncology Companion Diagnostic Market, by Polymerase Chain Reaction, by Region, 2019-2032 (USD Billion)
- 5.6. Others
- 5.6.1. Global Oncology Companion Diagnostic Market, by Others, by Region, 2019-2032 (USD Billion)
6. Global Oncology Companion Diagnostic Market, by Offering
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 6.3. Product
- 6.3.1. Global Oncology Companion Diagnostic Market, by Product, by Region, 2019-2032 (USD Billion)
- 6.4. Services
- 6.4.1. Global Oncology Companion Diagnostic Market, by Services, by Region, 2019-2032 (USD Billion)
7. Global Oncology Companion Diagnostic Market, by Disease Type
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Oncology Companion Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
- 7.3. Melanoma
- 7.3.1. Global Oncology Companion Diagnostic Market, by Melanoma, by Region, 2019-2032 (USD Billion)
- 7.4. Breast Cancer
- 7.4.1. Global Oncology Companion Diagnostic Market, by Breast Cancer, by Region, 2019-2032 (USD Billion)
- 7.5. Colorectal Cancer
- 7.5.1. Global Oncology Companion Diagnostic Market, by Colorectal Cancer, by Region, 2019-2032 (USD Billion)
- 7.6. Leukaemia
- 7.6.1. Global Oncology Companion Diagnostic Market, by Leukaemia, by Region, 2019-2032 (USD Billion)
- 7.7. Prostate Cancer
- 7.7.1. Global Oncology Companion Diagnostic Market, by Prostate Cancer, by Region, 2019-2032 (USD Billion)
- 7.8. Others
- 7.8.1. Global Oncology Companion Diagnostic Market, by Others, by Region, 2019-2032 (USD Billion)
8. Global Oncology Companion Diagnostic Market, by End User
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 8.3. Hospitals
- 8.3.1. Global Oncology Companion Diagnostic Market, by Hospitals, by Region, 2019-2032 (USD Billion)
- 8.4. Diagnostic Labs
- 8.4.1. Global Oncology Companion Diagnostic Market, by Diagnostic Labs, by Region, 2019-2032 (USD Billion)
- 8.5. Others
- 8.5.1. Global Oncology Companion Diagnostic Market, by Others, by Region, 2019-2032 (USD Billion)
9. Global Oncology Companion Diagnostic Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. Oncology Companion Diagnostic Market Assessment, By Geography, 2019-2032 (USD Billion)
- 9.3. Oncology Companion Diagnostic Market - North America
- 9.3.1. North America: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.3.2. North America: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.3.3. North America: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.3.4. North America: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.3.5. Oncology Companion Diagnostic Market - U.S.
- 9.3.5.1. U.S.: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.3.5.2. U.S.: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.3.5.3. U.S.: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.3.5.4. U.S.: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.3.6. Oncology Companion Diagnostic Market - Canada
- 9.3.6.1. Canada: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.3.6.2. Canada: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.3.6.3. Canada: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.3.6.4. Canada: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.4. Oncology Companion Diagnostic Market - Europe
- 9.4.1. Europe: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.4.2. Europe: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.4.3. Europe: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.4.4. Europe: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.4.5. Oncology Companion Diagnostic Market - UK
- 9.4.5.1. UK: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.4.5.2. UK: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.4.5.3. UK: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.4.5.4. UK: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.4.6. Oncology Companion Diagnostic Market - France
- 9.4.6.1. France: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.4.6.2. France: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.4.6.3. France: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.4.6.4. France: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.4.7. Oncology Companion Diagnostic Market - Germany
- 9.4.7.1. Germany: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.4.7.2. Germany: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.4.7.3. Germany: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.4.7.4. Germany: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.4.8. Oncology Companion Diagnostic Market - Italy
- 9.4.8.1. Italy: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.4.8.2. Italy: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.4.8.3. Italy: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.4.8.4. Italy: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.4.9. Oncology Companion Diagnostic Market - Spain
- 9.4.9.1. Spain: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.4.9.2. Spain: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.4.9.3. Spain: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.4.9.4. Spain: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.4.10. Oncology Companion Diagnostic Market - Netherlands
- 9.4.10.1. Netherlands: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.4.10.2. Netherlands: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.4.10.3. Netherlands: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.4.10.4. Netherlands: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.4.11. Oncology Companion Diagnostic Market - Russia
- 9.4.11.1. Russia: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.4.11.2. Russia.: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.4.11.3. Russia: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.4.11.4. Russia: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.5. Oncology Companion Diagnostic Market - Asia Pacific
- 9.5.1. Asia Pacific: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.5.2. Asia Pacific: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.5.3. Asia Pacific: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.5.4. Asia Pacific: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.5.5. Oncology Companion Diagnostic Market - China
- 9.5.5.1. China: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.5.5.2. China.: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.5.5.3. China: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.5.5.4. China: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.5.6. Oncology Companion Diagnostic Market - India
- 9.5.6.1. India: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.5.6.2. India.: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.5.6.3. India: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.5.6.4. India: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.5.7. Oncology Companion Diagnostic Market - Japan
- 9.5.7.1. Japan: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.5.7.2. Japan.: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.5.7.3. Japan: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.5.7.4. Japan: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.5.8. Oncology Companion Diagnostic Market - Malaysia
- 9.5.8.1. Malaysia: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.5.8.2. Malaysia.: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.5.8.3. Malaysia: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.5.8.4. Malaysia: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.5.9. Oncology Companion Diagnostic Market - Indonesia
- 9.5.9.1. Indonesia: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.5.9.2. Indonesia.: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.5.9.3. Indonesia: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.5.9.4. Indonesia: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.5.10. Oncology Companion Diagnostic Market - South Korea
- 9.5.10.1. South Korea: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.5.10.2. South Korea.: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.5.10.3. South Korea: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.5.10.4. South Korea: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.6. Oncology Companion Diagnostic Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.6.2. Middle East & Africa: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.6.3. Middle East & Africa: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.6.4. Middle East & Africa: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.6.5. Oncology Companion Diagnostic Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.6.5.2. Saudi Arabia: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.6.5.3. Saudi Arabia: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.6.5.4. Saudi Arabia: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.6.6. Oncology Companion Diagnostic Market - South Africa
- 9.6.6.1. South Africa: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.6.6.2. South Africa: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.6.6.3. South Africa: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.6.6.4. South Africa: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.6.7. Oncology Companion Diagnostic Market - Israel
- 9.6.7.1. Israel: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.6.7.2. Israel: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.6.7.3. Israel: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.6.7.4. Israel: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.6.8. Oncology Companion Diagnostic Market - UAE
- 9.6.8.1. UAE: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.6.8.2. UAE: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.6.8.3. UAE: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.6.8.4. UAE: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.7. Oncology Companion Diagnostic Market - Latin America
- 9.7.1. Latin America: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.7.2. Latin America: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.7.3. Latin America: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.7.4. Latin America: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.7.5. Oncology Companion Diagnostic Market - Mexico
- 9.7.5.1. Mexico: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.7.5.2. Mexico: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.7.5.3. Mexico: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.7.5.4. Mexico: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.7.6. Oncology Companion Diagnostic Market - Brazil
- 9.7.6.1. Brazil: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.7.6.2. Brazil: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.7.6.3. Brazil: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.7.6.4. Brazil: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- 9.7.7. Oncology Companion Diagnostic Market - Argentina
- 9.7.7.1. Argentina: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- 9.7.7.2. Argentina: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- 9.7.7.3. Argentina: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- 9.7.7.4. Argentina: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Abbott Laboratories
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Agilent Technologies
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Bio-Rad Laboratories
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Biocartis
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Exact Sciences
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Genedrive
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Genomic Health
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Guardant Health
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Illumina
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Invivoscribe
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Myriad Genetics
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. QIAGEN
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
- 11.13. Roche Diagnostics
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
- 11.14. Sysmex Corporation
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
- 11.15. Thermo Fisher Scientific
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development
Product Code: PM4133
List of Tables
- Table 1 Global Oncology Companion Diagnostic Market, by Technology, by Region, 2019-2032 (USD Billion)
- Table 2 Global Oncology Companion Diagnostic Market, by Offering, by Region, 2019-2032 (USD Billion)
- Table 3 Global Oncology Companion Diagnostic Market, by Disease type, by Region, 2019-2032 (USD Billion)
- Table 4 Global Oncology Companion Diagnostic Market, by End User, by Region, 2019-2032 (USD Billion)
- Table 5 Oncology Companion Diagnostic Market Assessment, By Geography, 2019-2032 (USD Billion)
- Table 6 North America: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 7 North America: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 8 North America: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 9 North America: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 10 U.S.: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 11 U.S.: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 12 U.S.: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 13 U.S.: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 14 Canada: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 15 Canada: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 16 Canada: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 17 Canada: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 18 Europe: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 19 Europe: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 20 Europe: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 21 Europe: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 22 Germany: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 23 Germany: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 24 Germany: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 25 Germany: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 26 France: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 27 France: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 28 France: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 29 France: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 30 UK: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 31 UK: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 32 UK: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 33 UK: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 34 Italy: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 35 Italy: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 36 Italy: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 37 Italy: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 38 Netherlands: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 39 Netherlands: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 40 Netherlands: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 41 Netherlands: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 42 Spain: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 43 Spain: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 44 Spain: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 45 Spain: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 46 Russia: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 47 Russia: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 48 Russia: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 49 Russia: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 50 Asia Pacific: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 51 Asia Pacific: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 52 Asia Pacific: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 53 Asia Pacific: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 54 China: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 55 China: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 56 China: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 57 China: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 58 Japan: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 59 Japan: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 60 Japan: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 61 Japan: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 62 India: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 63 India: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 64 India: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 65 India: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 66 Indonesia: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 67 Indonesia: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 68 Indonesia: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 69 Indonesia: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 70 Malaysia: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 71 Malaysia: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 72 Malaysia: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 73 Malaysia: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 74 South Korea: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 75 South Korea: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 76 South Korea: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 77 South Korea: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 78 Latin America: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 79 Latin America: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 80 Latin America: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 81 Latin America: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 82 Brazil: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 83 Brazil: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 84 Brazil: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 85 Brazil: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 86 Mexico: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 87 Mexico: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 88 Mexico: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 89 Mexico: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 90 Argentina: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 91 Argentina: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 92 Argentina: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 93 Argentina: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 94 Middle East & Africa: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 95 Middle East & Africa: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 96 Middle East & Africa: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 97 Middle East & Africa: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 98 UAE: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 99 UAE: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 100 UAE: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 101 UAE: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 102 Saudi Arabia: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 103 Saudi Arabia: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 104 Saudi Arabia: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 105 Saudi Arabia: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 106 South Africa: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 107 South Africa: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 108 South Africa: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 109 South Africa: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
- Table 110 Israel: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
- Table 111 Israel: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
- Table 112 Israel: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
- Table 113 Israel: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
List of Figures
- Figure 1. Global Oncology Companion Diagnostic Market, 2019-2032 (USD Billion)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up End User
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Technology
- Figure 7. Global Oncology Companion Diagnostic Market, by Technology, 2021 & 2030 (USD Billion)
- Figure 8. Market by End User
- Figure 9. Global Oncology Companion Diagnostic Market, by End User, 2021 & 2030 (USD Billion)
- Figure 10. Market by Offering
- Figure 11. Global Oncology Companion Diagnostic Market, by Offering, 2021 & 2030 (USD Billion)
- Figure 12. Market by Disease type
- Figure 13. Global Oncology Companion Diagnostic Market, by Disease type, 2021 & 2030 (USD Billion)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.